On these pages you can check out the latest breast cancer news from BCAC and our member groups. We also provide up-to-date information and links to current breast cancer research and clinical trials. Read latest stories below, or use the filters or the pager below for other stories. Use the form to the right of this to subscribe to our e-News.
Progress continues to be made through world-leading research to identify which treatments will work best for different sub-types of breast cancer.
Breast Cancer Aotearoa Coalition (BCAC) is 100% behind Blair Vining’s petition to Parliament calling for a national cancer agency to address New Zealand’s cancer death rates.
Malaghan Institute media release
In brilliant news, it has been discovered that adding ribociclib to first-line endocrine therapy significantly improves both progression free and overall survival (PFS and OS) for premenopausal women with advanced breast cancer.
The Waikato Breast Cancer Research Trust (WBCRT) is seeking participants with moderately severe treatment-resistant lymphoedema for this research. Is lymphoedema of your arm an ongoing problem for you? Have you undergone at least three months of lymphoedema therapy?
Key findings announced at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago include breakthroughs in the treatment of breast cancer and research. In a series of articles including this one, we outline some of the exciting developments reported.
Women who give so much to their families and communities now need help from the community to contribute to funding the medicines they need to treat their advanced breast cancer. These medicines help extend lives and improve quality of life.
We are thrilled that Lachlan McKenzie (38) has decided to run his first marathon for BCAC. Lachlan’s mum, Julie Bunnell, has advanced breast cancer, and Lachlan is running for BCAC because of the support we give women like her.
Media Release of the Breast Cancer Aotearoa Coalition and Lung Foundation New Zealand
BCAC and Lung Foundation NZ media release, 3 May...